Is Sofosbuvir Velpatasvir generic?

Harvoni’s new generic is ledipasvir/sofosbuvir and Epclusa’s new generic is velpatasvir/sofosbuvir. Both of these new generics are exact replicas of their brand-name counterparts, with the same forms and strengths.

Who makes Sofosbuvir Velpatasvir?

Epclusa (ep-KLOO-suh) is a fixed dose combination of sofosbuvir and velpatasvir (Figure 1). It is manufactured by Gilead Sciences.

What is the brand name for sofosbuvir?

Sofosbuvir, sold under the brand name Sovaldi among others, is a medication used to treat hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir, daclatasvir, or velpatasvir.

How much does Sofosbuvir Velpatasvir cost?

This is a generic drug. The average cost for 1 Box, 28 tablets each of the generic (sofosbuvir-velpatasvir) is $9,600.99.

What kind of Medicine is sofosbuvir and velpatasvir?

Sofosbuvir and velpatasvir are antiviral medications that prevent hepatitis C virus (HCV) from multiplying in your body. Sofosbuvir and velpatasvir is a combination medicine used to treat chronic hepatitis C in adults.

Is there a generic version of sofosbuvir in Bangladesh?

Beacon Pharmaceuticals, Bangladesh, introduced a generic version product under the trade name of Sofosvel. Beacon got approval from the Directorate of Drug Administration, Ministry of Health and Family Welfare, People’s Republic of Bangladesh.

When was velpatasvir approved for use in Europe?

Velpatasvir/sofosbuvir was developed by the pharmaceutical company Gilead Sciences and approved by US FDA in June 2016. In the European Union it was approved on 6 July 2016 for the treatment of chronic hepatitis C virus infection in adults.

How much does sofosbuvir-velpatasvir cost per pill?

Cost and Medication Access. The wholesale acquisition cost (WAC) for sofosbuvir-velpatasvir is $890 per pill; the cost of 12-week course of therapy is $74,760.